Phibro Current Deferred Revenue vs Net Invested Capital Analysis

PAHC Stock

USD 18.21 0.10 0.55%

Phibro Animal financial indicator trend analysis is much more than just breaking down Phibro Animal Health prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Phibro Animal Health is a good investment. Please check the relationship between Phibro Animal Current Deferred Revenue and its Net Invested Capital accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Phibro Animal Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.

Current Deferred Revenue vs Net Invested Capital

Current Deferred Revenue vs Net Invested Capital Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Phibro Animal Health Current Deferred Revenue account and Net Invested Capital. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Phibro Animal's Current Deferred Revenue and Net Invested Capital is 0.4. Overlapping area represents the amount of variation of Current Deferred Revenue that can explain the historical movement of Net Invested Capital in the same time period over historical financial statements of Phibro Animal Health, assuming nothing else is changed. The correlation between historical values of Phibro Animal's Current Deferred Revenue and Net Invested Capital is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Current Deferred Revenue of Phibro Animal Health are associated (or correlated) with its Net Invested Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Invested Capital has no effect on the direction of Current Deferred Revenue i.e., Phibro Animal's Current Deferred Revenue and Net Invested Capital go up and down completely randomly.

Correlation Coefficient

0.4

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Current Deferred Revenue

Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.

Net Invested Capital

The total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents.

Most indicators from Phibro Animal's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Phibro Animal Health current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Phibro Animal Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.

The current year's Sales General And Administrative To Revenue is expected to grow to 0.20, whereas Selling General Administrative is forecasted to decline to about 133.1 M.

	2022	2023	2024 (projected)
Interest Expense	17.9M	16.2M	18.1M
Depreciation And Amortization	34.0M	39.1M	41.1M

Interest Expense Depreciation And Amortization

Phibro Animal fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt
Total Assets		0.74	-0.12	0.83	0.91	-0.29	0.98	0.72	0.9	0.68	0.47	0.99	0.34	0.34	0.66	0.87	0.75	-0.22	0.68	0.99	0.9	0.79	0.74	0.9	0.8	0.84
Short Long Term Debt Total	0.74		-0.04	0.9	0.56	-0.11	0.72	0.99	0.57	0.84	0.6	0.72	0.29	0.18	0.64	0.68	0.81	-0.4	0.98	0.75	0.72	0.53	0.99	0.67	0.92	0.59
Other Current Liab	-0.12	-0.04		0.07	-0.23	0.05	-0.15	-0.07	-0.18	0.2	0.14	-0.18	0.02	-0.46	0.05	0.03	-0.15	-0.19	-0.01	-0.09	-0.06	-0.25	0.01	-0.03	-0.08	-0.13
Total Current Liabilities	0.83	0.9	0.07		0.74	-0.28	0.78	0.86	0.74	0.9	0.68	0.79	0.32	0.23	0.6	0.86	0.9	-0.28	0.84	0.81	0.74	0.66	0.91	0.7	0.97	0.73
Total Stockholder Equity	0.91	0.56	-0.23	0.74		-0.49	0.88	0.54	0.98	0.53	0.4	0.93	0.54	0.53	0.43	0.83	0.78	0.13	0.45	0.87	0.72	0.78	0.54	0.79	0.76	0.86
Other Liab	-0.29	-0.11	0.05	-0.28	-0.49		-0.36	-0.1	-0.58	-0.03	-0.06	-0.3	-0.63	-0.19	-0.36	-0.31	-0.31	-0.64	0.1	-0.2	-0.29	0.07	0.0	-0.39	-0.25	-0.61
Property Plant And Equipment Net	0.98	0.72	-0.15	0.78	0.88	-0.36		0.72	0.88	0.62	0.37	0.97	0.36	0.25	0.75	0.8	0.69	-0.18	0.65	0.97	0.95	0.71	0.7	0.95	0.75	0.87
Net Debt	0.72	0.99	-0.07	0.86	0.54	-0.1	0.72		0.55	0.77	0.46	0.71	0.29	0.13	0.67	0.62	0.77	-0.38	0.97	0.73	0.74	0.51	0.97	0.67	0.89	0.6
Retained Earnings	0.9	0.57	-0.18	0.74	0.98	-0.58	0.88	0.55		0.51	0.4	0.92	0.59	0.51	0.49	0.85	0.75	0.2	0.44	0.84	0.73	0.67	0.54	0.8	0.75	0.91
Accounts Payable	0.68	0.84	0.2	0.9	0.53	-0.03	0.62	0.77	0.51		0.79	0.62	0.18	0.08	0.48	0.69	0.81	-0.44	0.83	0.71	0.62	0.6	0.88	0.6	0.86	0.48
Cash	0.47	0.6	0.14	0.68	0.4	-0.06	0.37	0.46	0.4	0.79		0.43	0.2	0.36	0.2	0.66	0.63	-0.28	0.59	0.44	0.3	0.38	0.63	0.31	0.66	0.28
Non Current Assets Total	0.99	0.72	-0.18	0.79	0.93	-0.3	0.97	0.71	0.92	0.62	0.43		0.41	0.41	0.63	0.85	0.73	-0.15	0.66	0.97	0.87	0.79	0.71	0.88	0.78	0.84
Non Currrent Assets Other	0.34	0.29	0.02	0.32	0.54	-0.63	0.36	0.29	0.59	0.18	0.2	0.41		0.5	0.04	0.28	0.47	0.63	0.15	0.28	0.18	0.14	0.2	0.42	0.41	0.49
Other Assets	0.34	0.18	-0.46	0.23	0.53	-0.19	0.25	0.13	0.51	0.08	0.36	0.41	0.5		-0.23	0.41	0.45	0.3	0.12	0.25	-0.02	0.38	0.16	0.11	0.35	0.26
Long Term Debt	0.66	0.64	0.05	0.6	0.43	-0.36	0.75	0.67	0.49	0.48	0.2	0.63	0.04	-0.23		0.52	0.33	-0.36	0.6	0.66	0.86	0.24	0.61	0.75	0.48	0.67
Cash And Short Term Investments	0.87	0.68	0.03	0.86	0.83	-0.31	0.8	0.62	0.85	0.69	0.66	0.85	0.28	0.41	0.52		0.72	-0.19	0.61	0.82	0.7	0.68	0.69	0.66	0.8	0.8
Net Receivables	0.75	0.81	-0.15	0.9	0.78	-0.31	0.69	0.77	0.75	0.81	0.63	0.73	0.47	0.45	0.33	0.72		-0.07	0.73	0.74	0.59	0.69	0.8	0.62	0.96	0.63
Common Stock Shares Outstanding	-0.22	-0.4	-0.19	-0.28	0.13	-0.64	-0.18	-0.38	0.2	-0.44	-0.28	-0.15	0.63	0.3	-0.36	-0.19	-0.07		-0.55	-0.3	-0.33	-0.3	-0.49	-0.14	-0.2	0.15
Non Current Liabilities Total	0.68	0.98	-0.01	0.84	0.45	0.1	0.65	0.97	0.44	0.83	0.59	0.66	0.15	0.12	0.6	0.61	0.73	-0.55		0.7	0.68	0.53	0.99	0.59	0.85	0.46
Inventory	0.99	0.75	-0.09	0.81	0.87	-0.2	0.97	0.73	0.84	0.71	0.44	0.97	0.28	0.25	0.66	0.82	0.74	-0.3	0.7		0.93	0.79	0.75	0.92	0.79	0.79
Other Current Assets	0.9	0.72	-0.06	0.74	0.72	-0.29	0.95	0.74	0.73	0.62	0.3	0.87	0.18	-0.02	0.86	0.7	0.59	-0.33	0.68	0.93		0.6	0.71	0.95	0.68	0.8
Other Stockholder Equity	0.79	0.53	-0.25	0.66	0.78	0.07	0.71	0.51	0.67	0.6	0.38	0.79	0.14	0.38	0.24	0.68	0.69	-0.3	0.53	0.79	0.6		0.58	0.57	0.69	0.53
Total Liab	0.74	0.99	0.01	0.91	0.54	0.0	0.7	0.97	0.54	0.88	0.63	0.71	0.2	0.16	0.61	0.69	0.8	-0.49	0.99	0.75	0.71	0.58		0.64	0.91	0.55
Property Plant And Equipment Gross	0.9	0.67	-0.03	0.7	0.79	-0.39	0.95	0.67	0.8	0.6	0.31	0.88	0.42	0.11	0.75	0.66	0.62	-0.14	0.59	0.92	0.95	0.57	0.64		0.67	0.82
Total Current Assets	0.8	0.92	-0.08	0.97	0.76	-0.25	0.75	0.89	0.75	0.86	0.66	0.78	0.41	0.35	0.48	0.8	0.96	-0.2	0.85	0.79	0.68	0.69	0.91	0.67		0.69
Short Term Debt	0.84	0.59	-0.13	0.73	0.86	-0.61	0.87	0.6	0.91	0.48	0.28	0.84	0.49	0.26	0.67	0.8	0.63	0.15	0.46	0.79	0.8	0.53	0.55	0.82	0.69

Click cells to compare fundamentals

Phibro Animal Account Relationship Matchups

Phibro Animal fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	784.1M	841.3M	931.7M	971.4M	1.1B	1.2B
Short Long Term Debt Total	410.7M	426.7M	470.5M	510.0M	586.5M	323.5M
Other Current Liab	21.2M	20.8M	73.4M	18.9M	17.0M	32.1M
Total Current Liabilities	157.2M	164.1M	190.8M	176M	202.4M	138.0M
Total Stockholder Equity	188.2M	238.5M	262.4M	282.5M	324.9M	341.1M
Other Liab	46.7M	28.0M	29.0M	31.3M	36.0M	39.1M
Property Plant And Equipment Net	171.0M	187.7M	203.2M	231.3M	266.0M	279.3M
Net Debt	374.4M	376.5M	396.2M	468.7M	539.0M	291.8M
Retained Earnings	183.1M	218.0M	247.7M	260.9M	300.0M	315.1M
Accounts Payable	66.1M	68.4M	95.6M	73.9M	84.9M	62.6M
Cash	36.3M	50.2M	74.2M	41.3M	47.5M	29.8M
Non Current Assets Total	332.3M	342.4M	365.5M	385.7M	443.5M	465.7M
Non Currrent Assets Other	16.2M	19.8M	29.0M	26.3M	23.7M	15.6M
Other Assets	33.4M	35.6M	28.0M	30.8M	35.5M	27.9M
Long Term Debt	368.3M	382.7M	417.9M	452.5M	520.4M	546.4M
Cash And Short Term Investments	91.3M	93.2M	91.2M	81.3M	93.5M	98.1M
Net Receivables	126.5M	146.9M	166.5M	163.5M	188.0M	116.1M
Liabilities And Stockholders Equity	784.1M	841.3M	931.7M	971.4M	1.1B	561.8M
Non Current Liabilities Total	438.7M	438.7M	478.4M	512.9M	589.8M	359.5M
Inventory	196.7M	216.3M	259.2M	277.6M	319.2M	335.2M
Other Current Assets	37.3M	42.5M	49.3M	63.4M	72.9M	76.5M
Other Stockholder Equity	129.9M	133.3M	135.5M	135.8M	156.2M	164.0M
Total Liab	595.9M	602.8M	669.3M	688.9M	792.2M	494.2M
Property Plant And Equipment Gross	171.0M	187.7M	444.1M	495.0M	569.2M	597.7M
Total Current Assets	451.8M	498.9M	566.2M	585.7M	673.6M	347.1M
Accumulated Other Comprehensive Income	(130.4M)	(115.3M)	(121.1M)	(114.2M)	(102.8M)	(97.6M)
Short Term Debt	25.2M	16.0M	21.1M	28.3M	25.5M	26.8M
Intangible Assets	71.0M	62.3M	63.9M	55.0M	63.2M	34.0M
Property Plant Equipment	171.0M	187.7M	165.5M	195.6M	224.9M	121.5M
Net Tangible Assets	64.5M	123.6M	145.4M	174.2M	200.4M	210.4M
Current Deferred Revenue	44.8M	58.9M	822K	54.9M	63.2M	39.4M
Retained Earnings Total Equity	183.1M	218.0M	247.7M	260.9M	300.0M	315.1M
Short Term Investments	55M	43M	17M	40M	46M	25.8M
Deferred Long Term Liab	1.0M	1.8M	1.4M	1.4M	1.3M	1.4M
Short Long Term Debt	18.8M	9.4M	15M	22.3M	20.1M	31.3M
Long Term Debt Total	229.8M	217.6M	417.9M	452.5M	520.4M	333.8M
Capital Surpluse	129.9M	133.3M	135.5M	135.8M	156.2M	142.6M

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Phibro Animal Health using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Fix portfolios for free

When determining whether Phibro Animal Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Phibro Animal's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Phibro Animal Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Phibro Animal Health Stock:

How To Invest In Phibro

Details

Is Phibro Stock a good investment?

Details

What is Phibro Animal's Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Phibro Animal Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.

Note that the Phibro Animal Health information on this page should be used as a complementary analysis to other Phibro Animal's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Complementary Tools for Phibro Stock analysis

When running Phibro Animal's price analysis, check to measure Phibro Animal's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Phibro Animal is operating at the current time. Most of Phibro Animal's value examination focuses on studying past and present price action to predict the probability of Phibro Animal's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Phibro Animal's price. Additionally, you may evaluate how the addition of Phibro Animal to your portfolios can decrease your overall portfolio volatility.

	Content Syndication Quickly integrate customizable finance content to your own investment portal
	Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets
	Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market.
	Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk
	Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios
	Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk
	Performance Analysis Check effects of mean-variance optimization against your current asset allocation
	Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities

Is Phibro Animal's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Phibro Animal. If investors know Phibro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Phibro Animal listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.16)

Dividend Share

0.48

Earnings Share

0.37

Revenue Per Share

24.678

Quarterly Revenue Growth

0.071

The market value of Phibro Animal Health is measured differently than its book value, which is the value of Phibro that is recorded on the company's balance sheet. Investors also form their own opinion of Phibro Animal's value that differs from its market value or its book value, called intrinsic value, which is Phibro Animal's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Phibro Animal's market value can be influenced by many factors that don't directly affect Phibro Animal's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Phibro Animal's value and its price as these two are different measures arrived at by different means. Investors typically determine if Phibro Animal is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Phibro Animal's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Phibro Current Deferred Revenue vs Net Invested Capital Analysis

Current Deferred Revenue vs Net Invested Capital

Current Deferred Revenue vs Net Invested Capital Correlation Analysis

Correlation Coefficient

Current Deferred Revenue

Net Invested Capital

Phibro Animal fundamental ratios Correlations

Phibro Animal Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Phibro Animal fundamental ratios Accounts

Becoming a Better Investor with Macroaxis

Build Optimal Portfolios

Align your risk with return expectations

Complementary Tools for Phibro Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Assets Total	+ 0.99	Total Assets
Inventory	+ 0.99	Total Assets
Net Debt	+ 0.99	Short Long Term Debt Total
Total Liab	+ 0.99	Short Long Term Debt Total
Total Liab	+ 0.99	Non Current Liabilities Total
Property Plant And Equipment Net	+ 0.98	Total Assets

Common Stock Shares Outstanding	- 0.64	Other Liab
Non Currrent Assets Other	- 0.63	Other Liab
Short Term Debt	- 0.61	Other Liab
Retained Earnings	- 0.58	Other Liab
Non Current Liabilities Total	- 0.55	Common Stock Shares Outstanding
Total Liab	- 0.49	Common Stock Shares Outstanding